WEC
COLL icon

Winslow Evans & Crocker’s Collegium Pharmaceutical COLL Stock Holding History

Winslow Evans & Crocker’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-46
Closed -$2K – 1179
2019
Q1 		$2K Hold
46
– – ﹤0.01% 1124
2018
Q4 		$2K Sell
46
-4,000
-99% -$68.4K ﹤0.01% 1009
2018
Q3 		$62K Hold
4,046
– – 0.02% 446
2018
Q2 		$98K Buy
4,046
+46
+1% +$1.13K 0.03% 374
2018
Q1 		$102K Buy
+4,000
New +$95.3K 0.03% 353

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Winslow Evans & Crocker's COLL Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of Collegium Pharmaceutical (COLL) in Q2 2019, closing a stake of 46 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in COLL in Q1 2018 and held it in 5 quarters. The position peaked at $102K in Q1 2018. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

  • Winslow Evans & Crocker reported no remaining Collegium Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 46 Collegium Pharmaceutical shares in Q2 2019, an estimated $2K.
  • Winslow Evans & Crocker first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 5 quarters.
  • Winslow Evans & Crocker's Collegium Pharmaceutical position peaked at $102K in Q1 2018.
  • 128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.